Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Increased risk of ovarian cancer in integrin beta3 Leu33Pro homozygotes.

Endocrine-related cancer - 1 Dec 2005

Bojesen S E, Kjaer S K, Høgdall E V S, Thomsen B L, Høgdall C K, Blaakaer J, Tybjaerg-Hansen A, Nordestgaard B G

Abstract excerpt

We previously demonstrated that integrin beta(3) Leu33Pro homozygotes have an increased risk of cancer, possibly most pronounced for ovarian cancer. We now test the latter hypothesis in case-control and prospective studies. We genotyped 463 Danish women with ovarian cancer, and 4291 women from the Danish general population. Calculation of odds ratios by conditional logistic regression was performed in the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged, 80 and over
Share to Amino Acid Substitution

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Homozygote

Share to Integrin beta3

Share to Leucine

Share to Odds Ratio

Share to Ovarian Neoplasms

Share to Proline

Source

Identifiers

PMID: 16322334
DOI: 10.1677/erc.1.01083

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 11 closest

Increased risk of ovarian cancer in integrin beta3 Leu33Pro homozygotes.PMID 16322334Read ↗

Integrin beta3 Leu33Pro homozygosity and risk of cancer.Semantic proximity Read ↗

The Leu33Pro polymorphism in the ITGB3 gene does not modify BRCA1/2-associated breast or ovarian cancer risks: results from a multicenter study among 15,542 BRCA1 and BRCA2 mutation carriers.Semantic proximity Read ↗

No association of breast cancer risk with integrin beta3 (ITGB3) Leu33Pro genotype.Semantic proximity Read ↗

Integrin beta3 Leu33Pro polymorphism and risk of hip fracture: 25 years follow-up of 9233 adults from the general population.Semantic proximity Read ↗

Intron variants of the p53 gene are associated with increased risk for ovarian cancer but not in carriers of BRCA1 or BRCA2 germline mutations.Semantic proximity Read ↗

Integrin beta-3 genetic variants and risk of venous thromboembolism in colorectal cancer patients.Semantic proximity Read ↗

Breast cancer susceptibility variants alter risk in familial ovarian cancer.Semantic proximity Read ↗

Integrin alpha-2 and beta-3 gene polymorphisms and colorectal cancer risk.Semantic proximity Read ↗

Lysyl oxidase G473A polymorphism is associated with increased risk of ovarian cancer.Semantic proximity Read ↗

Association between lysyl oxidase G473A polymorphism and ovarian cancer in the Han Chinese population.Semantic proximity Read ↗

Integrin alpha-2 and beta-3 gene polymorphisms and breast cancer risk.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.